{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:21:16Z","timestamp":1783621276434,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.amjcard.2026.05.021","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:49:48Z","timestamp":1779864588000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Direct Oral Anticoagulants Versus Warfarin in Durable Left Ventricular Assist Device Recipients Without Atrial Fibrillation"],"prefix":"10.1016","volume":"272","author":[{"given":"Atef","family":"Akoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Nasser El","family":"Shabrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Elbahloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa El Deen","family":"Wehbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masah","family":"Ateeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-7591","authenticated-orcid":false,"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.05.021_bib0001","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ejhf.779","article-title":"Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes","volume":"19","author":"Gustafsson","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0002","doi-asserted-by":"crossref","first-page":"521","DOI":"10.21037\/atm-20-4849","article-title":"Antiplatelet and anticoagulation strategies for left ventricular assist devices","volume":"9","author":"Loyaga-Rendon","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2023.01.009","article-title":"HFSA expert consensus statement on the medical management of patients on durable mechanical circulatory support","volume":"29","author":"Trachtenberg","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0004","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ejcts\/ezu510","article-title":"Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices","volume":"48","author":"Baghai","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102871","article-title":"Direct oral anticoagulants versus warfarin in adults with durable left ventricular assist devices: a systematic review and meta-analysis","volume":"49","author":"Mhanna","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MAT.0000000000001572","article-title":"Time in therapeutic range significantly impacts survival and adverse events in destination Therapy patients","volume":"68","author":"Macaluso","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0008","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/14779072.2020.1773803","article-title":"Anticoagulant treatment and bleeding complications in patients with left ventricular assist devices","volume":"18","author":"den Exter","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0009","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MAT.0000000000000592","article-title":"Anticoagulation control in patients with ventricular assist devices","volume":"63","author":"Boehme","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0010","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jchf.2024.04.013","article-title":"Evaluation of the hemocompatibility of the direct oral anticoagulant apixaban in left ventricular assist devices: the DOAC LVAD Study","volume":"12","author":"Shah","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0011","article-title":"Increased thromboembolic events with Dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0012","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/ehf2.15182","article-title":"Long-term outcomes of apixaban as main anticoagulant in patients with HeartMate 3 left ventricular assist devices","volume":"12","author":"Jdaidani","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MAT.0000000000001650","article-title":"Apixaban: alternative anticoagulation for HeartMate 3 Ventricular Assist device","volume":"68","author":"Whitehouse","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2024.05.036","article-title":"Comparing Apixaban with Warfarin for therapeutic anticoagulation in left ventricular assist devices","volume":"224","author":"Soares","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0016","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.healun.2019.02.009","article-title":"Prothrombotic activity of cytokine-activated endothelial cells and shear-activated platelets in the setting of ventricular assist device support","volume":"38","author":"Apostoli","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0017","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.jacc.2015.09.083","article-title":"Fully magnetically levitated Left Ventricular Assist system for treating advanced HF: a multicenter study","volume":"66","author":"Netuka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0018","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.05.021_bib0019","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left Ventricular assist device - final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926003693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926003693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:01:41Z","timestamp":1783620101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926003693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0002914926003693"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.05.021","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct Oral Anticoagulants Versus Warfarin in Durable Left Ventricular Assist Device Recipients Without Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}